StonvexLoading…
StonvexStonvexStonvexCore line items from CTSO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2023 2023-09-30 |
|---|---|---|---|---|
Revenue | $37.06M | $35.59M | $31.08M | $8.81M |
Operating Income | $-14.75M | $-16.45M | $-31.95M | $-7.35M |
Net Income | $-8.20M | $-20.72M | $-29.25M | $-9.19M |
EPS (Diluted) | $-0.13 | $-0.38 | $-0.65 | $-0.52 |
Total Assets | $44.18M | $47.37M | $52.96M | $47.58M |
Total Liabilities | $38.28M | $36.27M | $29.48M | $28.76M |
Cash & Equivalents | $6.25M | $3.28M | $14.13M | Not available |
Free Cash Flow OCF − CapEx | $-12.54M | $-14.71M | $-22.19M | Not available |
Shares Outstanding | 62.80M | 54.83M | 54.24M | Not available |